Syra Health Corp (SYRA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net revenues | 1,946,199 | 1,857,774 | 2,253,336 | 1,969,681 |
| Cost of services | 1,193,304 | 1,268,618 | 1,585,038 | 1,619,674 |
| Gross profit | 752,895 | 589,156 | 668,298 | 350,007 |
| Selling, general and administrative expenses | 289,070 | 287,287 | 288,305 | 456,572 |
| Salaries and benefits | 326,354 | 507,207 | 594,738 | 847,064 |
| Research and development expenses | 29,712 | 37,173 | 34,821 | 277,894 |
| Professional services | 164,939 | 224,026 | 153,803 | 141,456 |
| Depreciation | 5,978 | 6,797 | 25,541 | 17,374 |
| Total operating expenses | 816,053 | 1,062,490 | 1,097,208 | 1,740,360 |
| Operating loss | -63,158 | -473,334 | -428,910 | -1,390,353 |
| Interest income | 3,420 | 4,298 | 13,641 | 3,826 |
| Interest expense | 3,858 | 3,229 | 2,266 | 3,729 |
| Total other income (expense) | -438 | 1,069 | 11,375 | 97 |
| Net loss | -63,596 | -472,265 | -417,535 | -1,390,256 |
| Net loss per common share - basic | -0.01 | -0.04 | -0.06 | -0.21 |
| Net loss per common share - diluted | -0.01 | -0.04 | -0.06 | -0.21 |
| Weighted average common shares outstanding - basic | 11,939,169 | 11,587,058 | 7,264,768 | 6,602,421 |
| Weighted average common shares outstanding - diluted | 11,939,169 | 11,587,058 | 7,264,768 | 6,602,421 |